Barclays Reiterates "Equal Weight" Rating for Aspen Aerogels (NYSE:ASPN)

Aspen Aerogels (NYSE:ASPN - Get Free Report)'s stock had its "equal weight" rating restated by analysts at Barclays in a research report issued on Thursday, MarketBeat Ratings reports. They presently have a $7.00 price target on the construction company's stock, down from their prior price target of $13.00. Barclays's price target suggests a potential upside of 21.21% from the company's current price.

Several other brokerages also recently commented on ASPN. B. Riley dropped their price objective on shares of Aspen Aerogels from $35.00 to $22.00 and set a "buy" rating for the company in a research note on Wednesday, February 19th. Seaport Res Ptn downgraded shares of Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 12th. TD Cowen raised shares of Aspen Aerogels to a "strong-buy" rating in a research note on Tuesday, March 11th. Roth Mkm dropped their price objective on shares of Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating for the company in a research note on Friday, February 14th. Finally, Canaccord Genuity Group dropped their price objective on shares of Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating for the company in a research note on Friday, February 14th. One analyst has rated the stock with a sell rating, three have issued a hold rating, seven have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Aspen Aerogels currently has an average rating of "Moderate Buy" and a consensus target price of $18.44.

Aspen Aerogels Price Performance

Shares of Aspen Aerogels stock traded down $0.19 on Thursday, reaching $5.78. 1,528,874 shares of the stock were exchanged, compared to its average volume of 2,007,640. The firm's 50 day moving average is $5.71 and its 200-day moving average is $9.36. Aspen Aerogels has a one year low of $4.16 and a one year high of $33.15. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. The firm has a market cap of $474.16 million, a PE ratio of 36.10 and a beta of 2.72.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The construction company reported ($0.06) earnings per share for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. The company had revenue of $78.72 million during the quarter, compared to the consensus estimate of $82.75 million. During the same quarter in the prior year, the firm posted ($0.02) EPS. The firm's quarterly revenue was down 16.7% on a year-over-year basis. As a group, analysts anticipate that Aspen Aerogels will post 0.17 EPS for the current fiscal year.

Insider Activity

In other Aspen Aerogels news, CEO Donald R. Young purchased 20,000 shares of the company's stock in a transaction dated Monday, May 12th. The stock was purchased at an average price of $5.35 per share, with a total value of $107,000.00. Following the completion of the purchase, the chief executive officer now owns 550,856 shares of the company's stock, valued at approximately $2,947,079.60. The trade was a 3.77% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Insiders own 3.40% of the company's stock.

Hedge Funds Weigh In On Aspen Aerogels

Several large investors have recently modified their holdings of ASPN. Barclays PLC raised its stake in Aspen Aerogels by 333.8% during the third quarter. Barclays PLC now owns 92,302 shares of the construction company's stock worth $2,557,000 after buying an additional 71,024 shares during the last quarter. Perigon Wealth Management LLC raised its stake in Aspen Aerogels by 66.8% during the fourth quarter. Perigon Wealth Management LLC now owns 34,451 shares of the construction company's stock worth $433,000 after buying an additional 13,796 shares during the last quarter. Journey Strategic Wealth LLC bought a new position in Aspen Aerogels during the fourth quarter worth $178,000. Greenwood Capital Associates LLC raised its stake in Aspen Aerogels by 5.0% during the fourth quarter. Greenwood Capital Associates LLC now owns 36,938 shares of the construction company's stock worth $439,000 after buying an additional 1,749 shares during the last quarter. Finally, Sargent Investment Group LLC raised its stake in Aspen Aerogels by 14.7% during the fourth quarter. Sargent Investment Group LLC now owns 371,049 shares of the construction company's stock worth $4,723,000 after buying an additional 47,680 shares during the last quarter. Institutional investors own 97.64% of the company's stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.